Today: 7 July 2026
Select Medical (NYSE:SEM) last trade ends above buyout as Gulfport takes S&P spot
7 July 2026
2 mins read

Select Medical (NYSE:SEM) last trade ends above buyout as Gulfport takes S&P spot

NEW YORK, July 7, 2026, 10:02 EDT

  • Select Medical last traded at $16.51 on June 30, just a penny above the $16.50 per share cash deal. The company asked for NYSE trading to be suspended before the open on July 1.
  • Trading volume in the last session hit 27.8 million shares, about 12 times the average listed on Yahoo Finance, based on market data.
  • S&P Dow Jones Indices swapped out Select Medical for Gulfport Energy in the S&P SmallCap 600 ahead of the open on July 1.
  • The main story in the stock is finished. What matters now is index removals, how options get settled in cash, and the company’s private debt.

NYSE was running normal hours at the dateline. July 7 isn’t a scheduled 2026 exchange holiday. Select Medical Holdings Corporation was off the board after being taken private by a group led by Executive Chairman Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe. The company told the NYSE to halt trading before the open on July 1.

The strange thing about the exit was the last print. Select Medical’s last quoted price hit $16.51, which is actually a penny above the $16.50 cash merger price. That difference may look tiny, but it matters for event-driven funds: anyone buying at that price paid above the cash-out level, not including fees. Final trade volume was 27.8 million shares, so that’s around $460 million in notional value at that price, using market data figures.

Public-market itemDataInvestor read
Last SEM close$16.51Sits just $0.01 over the merger cash
Cash deal$16.50 a shareNo interest on shares eligible for the deal
Volume in last session27.8 mln sharesRoughly 12 times what trades most days
Normal average volume2.31 mln sharesFinal session saw elevated turnover
Prev market cap$2.05 blnSits under $3.9 bln company transaction value

The SEC filing details the deal terms. Eligible shares got $16.50 in cash per share, but excluded and rollover shares didn’t get cash the same way. Select Medical said the total payout was about $1.7 billion for the shares in the deal. The buyers used equity, some rollovers, and third-party debt. Also, a credit amendment put on a $1.0 billion incremental term loan.

Options were not adjusted after the $16.51 trade. The Options Clearing Corporation has set the new SEM option deliverable at $1,650 cash per contract, which is $16.50 for each of 100 shares, with settlement going through OCC’s system.

Index funds saw a more abrupt shuffle than the stocks themselves. Gulfport Energy Corp. was added to the S&P SmallCap 600 before the July 1 open, replacing Select Medical as Select gets acquired. The swap moved the index slot from a health-care facilities stock to an energy stock.

Effective dateIndexActionCompanyTickerSector
July 1, 2026S&P SmallCap 600Will addGulfport Energy Corp.GPOREnergy
July 1, 2026S&P SmallCap 600Will dropSelect Medical Holdings CorporationSEMHealth Care

Select Medical had given its spending priorities in advance. On the May earnings call, CEO Thomas Mullin said the company planned to “continue to focus on expanding our inpatient rehabilitation business.” CFO Michael Malatesta told investors, “We are maintaining our full-year 2026 guidance.” The Motley Fool

The guidance outlined $5.6 billion to $5.8 billion in revenue for 2026, adjusted EBITDA between $520 million and $540 million, and diluted EPS in a $1.22 to $1.32 range. Public equity markets no longer trade that outlook, but lenders are still watching the gap between rehab growth and softness in critical illness recovery hospitals.

Mullin told analysts the company is seeing “more denials in the Medicare Advantage space” affecting its hospitals. Malatesta estimated the year-over-year drop in volume from weaker Medicare Advantage conversion rates is costing about $13 million to $14 million. The Motley Fool

Q1 2026 segmentRevenueAdj. EBITDAMarginYear-earlier margin
Critical illness recovery hospitals$638.8 mln$73.4 mln11.5%13.6%
Rehabilitation hospitals$351.9 mln$81.1 mln23.0%22.9%
Outpatient rehabilitation$321.3 mln$22.0 mln6.8%7.9%

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets.

Stock Market Today

  • Estate Planning: Lawyer or Financial Adviser?
    July 7, 2026, 10:23 AM EDT. Estate planning means setting up your assets and instructions for after you die. It's smart to get more than one advisor to check your plan, but you need a legal specialist to actually write and legitimize the paperwork. Lawyers know how to keep wills, trusts, and powers of attorney legal. Financial advisers offer investment and asset advice, but they can't do the legal work. You might use both, but a lawyer is necessary to avoid legal trouble and make sure everything stands up in court.
Pop Culture Group (NASDAQ:CPOP) rises premarket, but below June pricing
Previous Story

Pop Culture Group (NASDAQ:CPOP) rises premarket, but below June pricing

Go toTop